William E. Wade

4.4k total citations · 2 hit papers
62 papers, 3.4k citations indexed

About

William E. Wade is a scholar working on Internal Medicine, Cardiology and Cardiovascular Medicine and Geriatrics and Gerontology. According to data from OpenAlex, William E. Wade has authored 62 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Internal Medicine, 19 papers in Cardiology and Cardiovascular Medicine and 19 papers in Geriatrics and Gerontology. Recurrent topics in William E. Wade's work include Venous Thromboembolism Diagnosis and Management (20 papers), Pharmaceutical Practices and Patient Outcomes (19 papers) and Atrial Fibrillation Management and Outcomes (12 papers). William E. Wade is often cited by papers focused on Venous Thromboembolism Diagnosis and Management (20 papers), Pharmaceutical Practices and Patient Outcomes (19 papers) and Atrial Fibrillation Management and Outcomes (12 papers). William E. Wade collaborates with scholars based in United States, Canada and Spain. William E. Wade's co-authors include James W. Cooper, Donna M. Fick, J. Ross Maclean, Jennifer L. Waller, Mark H. Beers, Floyd E. Dewhirst, William J. Spruill, Marie A. Chisholm, Jeffrey A. Kotzan and Bradley C. Martin and has published in prestigious journals such as Pharmaceutical Research, Transplantation and Clinical Pharmacology & Therapeutics.

In The Last Decade

William E. Wade

60 papers receiving 3.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Updating the Beers Criteria for Potentially Inappropriate Medication Use in Older Adults

2003 1.8k citations James W. Cooper, William E. Wade et al. profile →
Bergey’s Manual of Systematic Bacteriology

2012 518 citations William E. Wade, Floyd E. Dewhirst Springer US profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
William E. Wade United States	18	1.6k	730	531	518	405	62	3.4k
Martin Schulz Germany	31	957 0.6×	341 0.5×	548 1.0×	537 1.0×	538 1.3×	155	4.1k
Nadine Shehab United States	27	1.5k 0.9×	603 0.8×	374 0.7×	986 1.9×	715 1.8×	42	5.1k
Katja Taxis Netherlands	32	1.5k 0.9×	481 0.7×	353 0.7×	375 0.7×	421 1.0×	192	3.6k
David O’Sullivan Ireland	17	2.1k 1.3×	1.1k 1.5×	626 1.2×	460 0.9×	372 0.9×	37	2.9k
Maribeth C. Lovegrove United States	20	1.1k 0.7×	461 0.6×	285 0.5×	585 1.1×	459 1.1×	38	3.4k
Sepehr Shakib Australia	32	3.2k 2.0×	1.7k 2.4×	1.0k 1.9×	1.1k 2.0×	498 1.2×	155	5.7k
Claudio Cricelli Italy	35	403 0.3×	517 0.7×	496 0.9×	1.5k 2.9×	268 0.7×	173	5.1k
Hege Salvesen Blix Norway	26	1.2k 0.8×	377 0.5×	316 0.6×	258 0.5×	503 1.2×	91	2.5k
Bruce Friedman United States	33	561 0.3×	414 0.6×	148 0.3×	371 0.7×	185 0.5×	112	4.1k
Pierre Olivier Lang Switzerland	29	1.3k 0.8×	625 0.9×	229 0.4×	363 0.7×	157 0.4×	128	3.2k

Countries citing papers authored by William E. Wade

Since Specialization

Citations

This map shows the geographic impact of William E. Wade's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William E. Wade with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William E. Wade more than expected).

Fields of papers citing papers by William E. Wade

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by William E. Wade. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William E. Wade. The network helps show where William E. Wade may publish in the future.

Co-authorship network of co-authors of William E. Wade

This figure shows the co-authorship network connecting the top 25 collaborators of William E. Wade. A scholar is included among the top collaborators of William E. Wade based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with William E. Wade. William E. Wade is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wade, William E. & Floyd E. Dewhirst. (2012). Bergey’s Manual of Systematic Bacteriology. Springer US. 518 indexed citations breakdown →

Cooper, James W. & William E. Wade. (2005). Pharmacist Interventions in Geriatric Nursing Facility NSAID Therapy: A One-Year Follow-up Study of Costs and Outcomes. The Consultant Pharmacist. 20(6). 492–497. 6 indexed citations

Spruill, William J., et al.. (2004). A Cost Analysis of Fondaparinux Versus Enoxaparin in Total Knee Arthroplasty. American Journal of Therapeutics. 11(1). 3–8. 17 indexed citations

Wade, William E., et al.. (2004). Cost Analysis of Fondaparinux Versus Enoxaparin as Venous Thromboembolism Prophylaxis in Hip Fracture Surgery. American Journal of Therapeutics. 11(3). 194–198. 7 indexed citations

Kotzan, Jeffrey A., et al.. (2002). Prevalence and patterns of concomitant use of selective serotonin reuptake inhibitors and other antidepressants in a high-cost polypharmacy cohort. Clinical Therapeutics. 24(2). 237–248. 14 indexed citations

Taylor, A. Thomas, et al.. (2001). Improved Health‐Related Quality of Life with SSRIs and other Antidepressants. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 21(2). 189–194. 11 indexed citations

Spruill, William J., et al.. (2001). Three Michaelis‐Menten Pharmacokinetic Dosing Methods Compared with Physician Dosing of Phenytoin in an Outpatient Neurology Practice. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 21(11). 1407–1414. 3 indexed citations

Kotzan, Jeffrey A., William E. Wade, & Hsin‐Hui Yu. (2001). Assessing NSAID Prescription Use as a Predisposing Factor for Gastroesophageal Reflux Disease in a Medicaid Population. Pharmaceutical Research. 18(9). 1367–1372. 87 indexed citations

Wade, William E. & William J. Spruill. (2001). Cost comparison of tinzaparin versus enoxaparin as deep venous thrombosis prophylaxis in spinal cord injury: preliminary data. Blood Coagulation & Fibrinolysis. 12(8). 619–625. 6 indexed citations

10.

Chisholm, Marie A., et al.. (2000). Influence of Interactive Videoconferencing on the Performance of Pharmacy Students and Instructors. American Journal of Pharmaceutical Education. 64(2). 152–158. 21 indexed citations

11.

Wade, William E. & David Hawkins. (2000). Cost Effectiveness of Outpatient Anticoagulant Prophylaxis After Total Hip Arthroplasty. Orthopedics. 23(4). 335–339. 9 indexed citations

12.

Chisholm, Marie A., et al.. (2000). Cost‐benefit analysis of a clinical pharmacist‐managed medication assistance program in a renal transplant clinic. Clinical Transplantation. 14(4). 304–307. 35 indexed citations

13.

Wade, William E.. (1999). Cost effectiveness of danaparoid compared with enoxaparin as deep vein thrombosis prophylaxis after hip replacement surgery.. PubMed. 28(4). 229–31. 4 indexed citations

14.

Wade, William E.. (1999). Assessment in Distance Learning: What Do Students Know and How Do We Know They Know It?. THE journal. 27(3). 94–96. 14 indexed citations

15.

Chisholm, Marie A., et al.. (1999). Implementation and Evaluation of a Disease Management Course in a New Curriculum. American Journal of Pharmaceutical Education. 63(3). 315–322. 2 indexed citations

16.

Kotzan, Jeffrey A., Bradley C. Martin, & William E. Wade. (1999). Persistence with Estrogen Therapy in a Postmenopausal Medicaid Population. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 19(3). 363–369. 15 indexed citations

17.

Wade, William E.. (1998). Cost analysis of ardeparin versus enoxaparin for the prophylaxis of deep vein thrombosis after knee arthroplasty. Clinical Therapeutics. 20(2). 347–351. 4 indexed citations

18.

Wade, William E., et al.. (1995). Pharmacist‐Managed Aminoglycoside Therapy in Combination With a β‐Lactam Agent in the Treatment of Nosocomial Pneumonia in Critically Ill Patients. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 15(2). 216–219. 4 indexed citations

19.

Wade, William E.. (1995). Pharmacoeconomic impact of a drug use evaluation of ceftriaxone in an acute-care medical center. Clinical Therapeutics. 17(5). 973–976. 3 indexed citations

20.

Wade, William E., et al.. (1990). Therapeutic Drug Monitoring in a Community Hospital. Therapeutic Drug Monitoring. 12(1). 79–81. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact